Today’s Solutions: July 26, 2026

On a busy street near a school in London, a newly painted crosswalk is designed to slow down drivers through an optical illusion: As someone approaches, each white stripe on the road looks like a three-dimensional block. The idea is that by catching the eye, the optical illusion will force drivers to concentrate more on the road rather than being distracted by other things.

London took inspiration from similar crosswalks in India and Iceland, which have thus far been successful. For the coming months, the city council will be monitoring the crossing with a camera to see how drivers react; one concern was that it would be so realistic that drivers might swerve to try to avoid the imaginary bumps, though there has been no evidence of that so far.

The government also wants to see what happens over time as local drivers become accustomed to the crossing; drivers who are new to the area, presumably, will continue to drive more cautiously because of the intervention. Should it work, we might start seeing more optical illusions on streets around the world.

Solutions News Source Print this article
More of Today's Solutions

Hindou Oumarou Ibrahim confronts climate crisis with Indigenous wisdom

According to Hindou Oumarou Ibrahim, “if you’re born as an Indigenous person, you’re born an activist, because you’re born with the problems surrounding your ...

Read More

From pilot to policy: a closer look at guaranteed income initiatives in the US

Michael D. Tubbs, mayor of Stockton, California, initiated a daring experiment in February 2019. He randomly selected 125 residents at or below the city's ...

Read More

Big Oil to pay for climate change damages in Vermont

Vermont became the first state in the United States to enact legislation mandating fossil fuel companies to pay for climate change-related losses. This unprecedented ...

Read More

A new CAR T-cell therapy for lupus brings hope for a cure

BY THE OPTIMIST DAILY EDITORIAL TEAM A new and promising treatment for lupus could mean the end of lifetime medication for patients suffering from ...

Read More